Abstract
AAEC scientists have developed a new radiopharmaceutical of commerical potential which can be applied to the diagnosis of diseases involving abnormal functioning of the liver, bile duct or gall bladder. It is technetium-bromo-BIMIDA. Other investigations include the enhancement of images from gallium-67 citrate in tumours and the interaction between iron dextran and technetium-pyro-phosphate.
Carrard, G
[1]
- comp.
Citation Formats
Carrard, G.
New substances for medical imaging.
Australia: N. p.,
1982.
Web.
Carrard, G.
New substances for medical imaging.
Australia.
Carrard, G.
1982.
"New substances for medical imaging."
Australia.
@misc{etde_5284734,
title = {New substances for medical imaging}
author = {Carrard, G}
abstractNote = {AAEC scientists have developed a new radiopharmaceutical of commerical potential which can be applied to the diagnosis of diseases involving abnormal functioning of the liver, bile duct or gall bladder. It is technetium-bromo-BIMIDA. Other investigations include the enhancement of images from gallium-67 citrate in tumours and the interaction between iron dextran and technetium-pyro-phosphate.}
journal = []
volume = {11}
journal type = {AC}
place = {Australia}
year = {1982}
month = {Mar}
}
title = {New substances for medical imaging}
author = {Carrard, G}
abstractNote = {AAEC scientists have developed a new radiopharmaceutical of commerical potential which can be applied to the diagnosis of diseases involving abnormal functioning of the liver, bile duct or gall bladder. It is technetium-bromo-BIMIDA. Other investigations include the enhancement of images from gallium-67 citrate in tumours and the interaction between iron dextran and technetium-pyro-phosphate.}
journal = []
volume = {11}
journal type = {AC}
place = {Australia}
year = {1982}
month = {Mar}
}